|
|
11804 North Creek Parkway South
Bothell, WA 98011 USA
phone:425-205-2900
fax:425-205-2901
|
|
| Symbol |
Private |
| Founded |
2004 |
| Employees |
|
|
|
| www.alderbio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapies for the treatment of cancer and rheumatoid arthritis. |
|
| Management |
| Randall C. Schatzman, Ph.D., President and Chief Executive Officer; John A. Latham, Ph.D., Chief Scientific Officer; Mark J. Litton, Ph.D., MBA, Chief Business Officer and Treasurer; Jeffrey T.L. Smith, M.D., FRCP, Chief Medical Officer; Larry Benedict, Vice President, Finance |
| |
|
|
| |
|
| Keywords |
| antibody potency, technologies, medical, treatment of cancer, biotechnology industry |
|
|
|
| Description |
|
From day one, Alder has worked to make a significant contribution to the field of antibody therapeutics using two proprietary platform technologies that accelerate antibody discovery and development. These technologies provide the foundation for addressing a range of unmet medical needs, and have allowed us to accelerate our first product into the clinic for the treatment of cancer and rheumatoid arthritis. |
|
| Technology / Differentiation |
| Alder has developed a unique antibody identification process that is able to identify very potent and rare therapeutic antibodies. The process enables rapid discovery directly from an immunized host using proprietary biological techniques. Unlike existing technologies, Alder?s ABS process has the ability to assess function directly at the outset while allowing broad epitope coverage. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members